Acumen Pharmaceuticals Inc (ABOS) stock has fallen -71.39% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ABOS stock a score of 26 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 3. ABOS's rank also includes a short-term technical score of 6. ABOS has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on ABOS!